All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Injectable Hyaluronic Acid Hydrogel Containing Platelet Derivatives for Synovial Fluid Viscosupplementation and Growth Factors Delivery

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F23%3A10459038" target="_blank" >RIV/00216208:11110/23:10459038 - isvavai.cz</a>

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=XUEQOOW6qu" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=XUEQOOW6qu</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/mabi.202200516" target="_blank" >10.1002/mabi.202200516</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Injectable Hyaluronic Acid Hydrogel Containing Platelet Derivatives for Synovial Fluid Viscosupplementation and Growth Factors Delivery

  • Original language description

    Osteoarthritisis a highly prevalent musculoskeletal disorder characterized by degradation ofcartilage and synovial fluid (SF). Platelet derivatives as platelet-rich plasma (PRP) and platelet lysatehave great potential in the treatment of osteoarthritis because they contain biologicallyactive substances including growth factors (GFs). Rapid release of GFs andtheir short biological half-life are factors that can limit the therapeuticimpact of PRP therapy. Here, the first work that describes hydrogels based onpolyaldehyde derivative of hyaluronic acid (HA-OX) as carriers of plateletderivatives for in situ applications is presented, which can be a possiblesolution to the problem. HA-OX hydrogels containing 50% (w/w) of PRP or platelet lysate can be injected using a syringe due to low viscosity(&lt;10 Pa s) and injection force (&lt;20 N), and reach elastic modulus upto 2000 Pa. Insulin-like GF-1 and Platelet-derived GF-AB release from HA-OX hydrogels (mesh size 297-406 nm) by Fickian and non-Fickian diffusion respectively. The released PRP GFs maintain their ability to induce cell proliferation (87%-92%). Based on the obtained results, the unique concept of a new material that canrestore viscoelastic properties of SF and at the same time gradually deliver GFs from platelet derivatives is designed.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30100 - Basic medicine

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Macromolecular Bioscience

  • ISSN

    1616-5187

  • e-ISSN

    1616-5195

  • Volume of the periodical

    23

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    14

  • Pages from-to

    2200516

  • UT code for WoS article

    000930163600001

  • EID of the result in the Scopus database

    2-s2.0-85147939224